Number and age at time of testing of piglets and gilts in both batches. by Sara Hintze (3216885)

Subjects:

Test apparatus. by Sara Hintze (3216885)

Subjects:

Regression model summary outputs: Skilled delivery (Continuous exposure). by Chelsea Ducille (21540080)

Subjects:

Projections of mortality for hematological malignancies in mainland China. by Yu Fu (16582)

Subjects:

Aerial view of Fire Zone 1 (a) and Fire Zone 3 (c); Mining disturbance geomorphology in Fire Zone 1 (b) and Fire Zone 3 (d). by Desheng Xie (21439869)

Subjects:

Study flow chart. by Johannes Nairz (18010746)

Subjects:

Proportion of time spent in the Start Room or Avoidance Room or showing a behaviour (Stimulus Contact) presented across stimuli and separately for female (n = 10) and male (n = 10)... by Sara Hintze (3216885)

Subjects:

Frequencies of different behaviours (Compartment Changes, Escape Attempts, Stimulus Orientation, Stimulus Approach, Stimulus Contact, Grunting, Barking, Excretion), the minimum dis... by Sara Hintze (3216885)

Subjects:

H& E staining investigation of CAM treated with native-orientin (5 μM), native-orientin (10 μM), NF-O (5 μM), and NF-O (10 μM). by Yashwanth Elumalai (21743452)

Subjects:

Dynamic light scattering (DLS) data of NF-O. by Yashwanth Elumalai (21743452)

Subjects:

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Subgroup and sensitivity analyses for the primary outcomes. by Jin-Min Gu (17915039)

Subjects:

Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

Subjects:

Flow diagram for the identification of studies included. by Jin-Min Gu (17915039)

Subjects:

Forest plot of the hospital stay length in distinct stages of patients. by Jin-Min Gu (17915039)

Subjects:

Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

Subjects:

Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality. by Jennifer M. Kwan (3350321)

Subjects:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

Subjects:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Subjects: